Recall: D-0750-2021

Class II - Potentially Harmful

Class IIClassification

2021-07-19Initiated

TerminatedStatus

Dr. Reddy's Laboratories, Inc.Firm

Product

Tizanidine HCl Tablets, USP 4 mg, 150-count bottles, Rx only, Mfd By: Dr. Reddy's Laboratories limited, Srikakulam District, 532 409 INDIA, NDC 55111-180-15.

Reason

Failed Tablet/Capsule Specification: Some tablets are shaved

Distribution

Nationwide within the United States

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.